Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
Abstract Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while im...
Saved in:
Main Authors: | Kashif Hussain, Rahila Ikram, Gul Ambreen, Muhammad Sohail Salat |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d8a77add683043fc942fb818ac2a6fe7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of pharmacists' perception toward continuing education
by: Nouf M Alharthi, et al.
Published: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021) -
Pharmacists and telemedicine: an innovative model fulfilling Sustainable Development Goals (SDGs)
by: Nadia Bukhari, et al.
Published: (2021) -
Bibliometric analysis of pharmacist’s research on antimicrobial stewardship in Japan: an interrupted time series analysis on the implementation of the certification system for infection control pharmacists
by: Masayuki Maeda, et al.
Published: (2021) -
Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration
by: Hadi A. Almansour, et al.
Published: (2021)